Antidepressant Fallout Includes Change In FDA Pediatric Study Procedure
Executive Summary
Studies conducted under the Best Pharmaceuticals for Children Act will be included in labeling, FDA Office of Medical Policy Director Robert Temple, MD, told the House Energy & Commerce/Oversight Subcommittee Sept. 23
You may also be interested in...
Pfizer Revises Zoloft Ad After FDA Cites Lack Of Suicide Information
Pfizer is revising Zoloft (sertraline) advertisements after FDA cited the company for not incorporating updated risk information in a print ad for the antidepressant
Pfizer Revises Zoloft Ad After FDA Cites Lack Of Suicide Information
Pfizer is revising Zoloft (sertraline) advertisements after FDA cited the company for not incorporating updated risk information in a print ad for the antidepressant
Office Of New Drugs Oversight Of Advisory Committees Creates Bias – Graham
The Office of New Drugs' authority over FDA advisory committees creates a bias in industry's favor, Office of Drug Safety Associate Director for Science David Graham said March 21 during a National Press Club "Newsmakers" conference in Washington, D.C